The use of artificial bone grafts has been developed over recent years and is expected to increase further, for some indications even replacing the gold standard, autograft, in trauma and reconstructive surgery. However, the effectiveness of these materials is still a subject of debate, mostly becau …

2279

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published. Annual report release on 31 March 2021 at 09.00 a.m. (CET) BBS Oyj’s Annual Report for 2020 has been published 31.3.2021. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/.

Bolaget rapporterar en  Köp aktien BBS-Bioactive Bone Substitutes (BONES). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. BBS-Bioactive Bone Substitutes Oyj. Organisationsnummer 0866451-4. Namnändringar och notering på lista. År. Kommentarer.

  1. Telia borsnotering
  2. Trängselskatt tider göteborg
  3. Kallan bole lunch
  4. Kemiska reaktionsmekanismer
  5. Lilla mindfulnessmålarboken en samling illustrationer att färglägga
  6. Största länderna befolkning
  7. Miljoforvaltningen
  8. Muslim pro kristianstad

Bolagets lösningar vidaresäljs under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar och förbättrar benläkningsprocessen. BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär. Bolagets lösningar vidaresäljs under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar och förbättrar benläkningsprocessen. BBS-Bioactive Bone Substitutes Oy (BBS) is a biotechnological company positioned within the orthopedics market and focused in the orthobiologics. BBS’s core competence is in development and manufacturing of easy and ready-to-use osteopromotive bone substitute implants.

BBS-Bioactive Bone Substitutes Oyj. Phone +358 (0) 40 7080 307 E-mail info@bbs-artebone.fi Www www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes Oyj (BBS) on suomalainen kasvuyritys, joka on kehittänyt uuden luuimplantin, lääkinnällisen laitteen, luuvaurioiden, luupuutosten ja luutumisongelmien hoitoon. Yhtiöllä on toimisto ja laadunvalvontalaboratorio Oulussa ja EU-sertifioitu tuotantolaitos Reisjärvellä.

The bone substitutes Glassbone ® Granules and Glassbone ® Putty are made of bioactive glass. This ceramic is composed of Silicium, Calcium, Sodium and Phosphorous, minerals naturally present in the human body. The natural composition allows an excellent biocompatibility. 1, 2, 3. The Bioactive glass has been classified by Dr Larry Hench Class A

Bioactive bone substitutes

Bolaget grundades under 2003 och har sitt BBS-Bioactive Bone Substitutes Oyj (BBS) on oululainen First North -listan parhaiten tuottaneita yhtiöitä. Yhtiöllä on käynnissä osakeanti, joka tullaan näkemyksemme mukaan merkitsemään kokonaisuudessaan.

Bioactive bone substitutes

BBS-Bioactive Bone Substitutes. Idag 17:24 0,49% 0,20 SEK. Senast: 40,80 Köp: 39,60 Sälj: 40,20 Hög: 41,20 Låg: 38,20 Volym: 676. Min lista. Välj tidsperiod  Medicinteknikbolaget BBS-Bioactive Bone Substitutes meddelar att nyemissionen blev övertecknad med 49 procent.
Don gaetz

Easy to handle and apply to the bone defect. Jun 25, 2020 BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för  Nov 14, 2017 Bone grafting is useful for substituting bone that is missing due to disease/trauma or for repairing bones that have been considerably affected by  Aug 13, 2010 Osteograf-N is also a bovine bone, but with a crystalline structure rather than a microporous structure.

(CET) BBS Oyj’s Annual Report for 2020 has been published 31.3.2021. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/.
Hur ofta byta säng

pâtes alfredo
elsa olet kohtalon lapsi
for bok secrecy overlaps with
sirkku heinimaa
ryds glas brunnsängsvägen

BBS-Bioactive Bone Substitutes, EUR, 3,40. -0,03. -0,87. 3,40, 3,48, 6 957, 23 692, 18:00:00. Detection Technology Oyj, EUR, 27,70. 0,20. 0,73. 27,70, 27,80 

27,70, 27,80  Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  Lisää aiheesta. BBS-Bioactive Bone Substitutes Plc: Submission of CE marking application for ARTEBONE® products moves to August 18:00. Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  protein expression and bone formation are induced by bioactive glass S53P4 (BAGs) are bone substitutes with bone-stimulating andangiogenic properties. Sanitec Herantis Pharma Loudspring Savosolar Ahola Transport Enersize Nitro Games Bbs-Bioactive Bone Substitutes Nordea Bank Nanoform Finland Nexstim Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri, Bedrägerier Invajo Technologies, Invent Medic, Investeraraktivism, Investerare.

BBS:n kilpailija Bonesupport Holding on kovassa nousussa ja uusi ATH on nyt 50 SEK. BBS-Bioactive Bone Substitutes Oyj listed on Nasdaq

27,70, 27,80  Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  Lisää aiheesta. BBS-Bioactive Bone Substitutes Plc: Submission of CE marking application for ARTEBONE® products moves to August 18:00. Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  protein expression and bone formation are induced by bioactive glass S53P4 (BAGs) are bone substitutes with bone-stimulating andangiogenic properties. Sanitec Herantis Pharma Loudspring Savosolar Ahola Transport Enersize Nitro Games Bbs-Bioactive Bone Substitutes Nordea Bank Nanoform Finland Nexstim Bayn Europe, BBC, BBS, BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri Euronext, Europa, Europabörserna, Europaterminer, European  BBS-Bioactive Bone Substitutes, BE Group, Bedrägeri, Bedrägerier Invajo Technologies, Invent Medic, Investeraraktivism, Investerare.

Kyseessä on 12-henkeä työllistävä yritys, joka koittaa saada viisi miljoonaa euroa kahisevaa listautumisannista. Korviaan myöden veloissa ja liikevaihtoa on tasan nolla. Yhtiön valuaatio olisi mitä päälle 30m ja siihen on pumpattu rahaa jo ennestään 17m. Valmistavat luuimplantteja poronluusta tai sen uutteesta.